Sort
82,697 grants matching “vaccine development”
Synthetic DNA & Novel Env Vaccine for HIV
$3,351,099David B. Weiner · Wistar Institute · U19 · FY2019 · AI
cGMP Manufacturing of Monoclonal Antibodies (mAbs) Against HIV
$3,349,931Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2024 · AI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$3,347,398Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Advanced Development of a Multivalent Vaccine Candidate for Lassa Fever
$3,347,060Matthias Johannes Schnell · Thomas Jefferson University · N01 · FY2025 · AI
SOUTH AFRICA MRC HIV PREVENTION TRIALS UNIT
$3,343,960Gita Ramjee · Medical Research Council Of South Africa · U01 · FY2006 · AI
MRCE for Biodefense and Emerging Infectious Diseases
$3,343,837Washington University · U54 · FY2003 · AI
The University of North Carolina Center for AIDS Research
$3,343,513Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2022 · AI
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV
$3,342,566Niranjan Sardesai · Viral Genomix, Inc. · N01 · FY2011 · AI
Development of an Effector-Memory T Cell AIDS Vaccine
$3,342,436Louis J. Picker · Oregon Health & Science University · P01 · FY2015 · AI
Bridging Antibody Fc-mediated Antiviral Functions Across Humans and Non-human Primates
$3,342,424Georgia D Tomaras · Duke University · P01 · FY2019 · AI
SHIV/HIV Env-Antibody Coevolution as a Guide to Iterative Vaccine Design
$3,342,300George M Shaw · University Of Pennsylvania · P01 · FY2017 · AI
Synthetic DNA & Novel Env Vaccine for HIV
$3,340,504David B. Weiner · Wistar Institute · U19 · FY2018 · AI
Multiple Approaches to Abeta Vaccination in Animal Models
$3,340,325Michael G Agadjanyan · Institute For Molecular Medicine · RF1 · FY2018 · AG
RCMI Center for Health Disparities Research
$3,339,271Deepak Kumar · North Carolina Central University · U54 · FY2022 · MD
Synthetic DNA & Novel Env Vaccine for HIV
$3,337,497David B. Weiner · Wistar Institute · U19 · FY2017 · AI
Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials Network
$3,337,030Benoit Masse · Fred Hutchinson Cancer Research Center · U01 · FY2009 · AI
Operations and Management support component
$3,336,044Barton F Haynes · Duke University · UM1 · FY2015 · AI
Adjuvant development within the context of a vaccine to protect against B. pertussis
$3,334,207Lisa Morici · Tulane University Of Louisiana · N01 · FY2019 · AI
Development of stable and rapidly acting adjuvanted vaccines for biodefense
$3,333,529Robert Newton Brey · Soligenix, Inc. · U01 · FY2011 · AI
Upgrading infectious disease research facilities at University of Louisville RBL
$3,333,333Kenneth E Palmer · University Of Louisville · G20 · FY2021 · AI
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention
$3,333,050Marc Michael Baum · Oak Crest Institute Of Science · U19 · FY2015 · AI
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT)
$3,331,802Abhijit Prakash Limaye · University Of Washington · U01 · FY2023 · AI
Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research
$3,330,000William Paul Duprex · University Of Pittsburgh At Pittsburgh · G20 · FY2021 · AI
Regional Biocontainment Laboratories Facility and Building System Upgrades Support
$3,329,854Herman F. Staats · Duke University · G20 · FY2021 · AI
Administrative Supplement for Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research
$3,329,737William Paul Duprex · University Of Pittsburgh At Pittsburgh · G20 · FY2022 · AI